These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33419779)

  • 1. Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy.
    Boreel DF; Span PN; Heskamp S; Adema GJ; Bussink J
    Clin Cancer Res; 2021 Jun; 27(11):2970-2978. PubMed ID: 33419779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
    Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
    Front Immunol; 2019; 10():407. PubMed ID: 30930892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy.
    Jayaprakash P; Vignali PDA; Delgoffe GM; Curran MA
    Annu Rev Med; 2022 Jan; 73():251-265. PubMed ID: 34699264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
    Shahabi V; Postow MA; Tuck D; Wolchok JD
    Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy.
    Wang B; Zhao Q; Zhang Y; Liu Z; Zheng Z; Liu S; Meng L; Xin Y; Jiang X
    J Exp Clin Cancer Res; 2021 Jan; 40(1):24. PubMed ID: 33422072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership.
    Chajon E; Castelli J; Marsiglia H; De Crevoisier R
    Crit Rev Oncol Hematol; 2017 Mar; 111():124-132. PubMed ID: 28259287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-Driven Immune Escape in the Tumor Microenvironment.
    Vito A; El-Sayes N; Mossman K
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of radiotherapy on the antitumor immune response. Possibilities to combine radiotherapy with immunotherapy].
    Lumniczky K; Sáfrány G
    Magy Onkol; 2016 Mar; 60(1):46-54. PubMed ID: 26934351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H
    Song X; Xu J; Liang C; Chao Y; Jin Q; Wang C; Chen M; Liu Z
    Nano Lett; 2018 Oct; 18(10):6360-6368. PubMed ID: 30247918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
    Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of radiotherapy in the age of immunotherapy.
    Sato H; Demaria S; Ohno T
    Jpn J Clin Oncol; 2021 Apr; 51(4):513-522. PubMed ID: 33561212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy.
    Wattenberg MM; Fahim A; Ahmed MM; Hodge JW
    Radiat Res; 2014 Aug; 182(2):126-38. PubMed ID: 24960415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity, Hypoxia, and Metabolism-the Ménage à Trois of Cancer: Implications for Immunotherapy.
    Riera-Domingo C; Audigé A; Granja S; Cheng WC; Ho PC; Baltazar F; Stockmann C; Mazzone M
    Physiol Rev; 2020 Jan; 100(1):1-102. PubMed ID: 31414610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Hypoxia: A Key Determinant of Microenvironment Hostility and a Major Checkpoint during the Antitumor Response.
    Francis A; Venkatesh GH; Zaarour RF; Zeinelabdin NA; Nawafleh HH; Prasad P; Buart S; Terry S; Chouaib S
    Crit Rev Immunol; 2018; 38(6):505-524. PubMed ID: 31002604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy and Radiation: Charting a Path Forward Together.
    Sridharan V; Schoenfeld JD
    Hematol Oncol Clin North Am; 2019 Dec; 33(6):1057-1069. PubMed ID: 31668206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?
    Janji B; Chouaib S
    Front Immunol; 2022; 13():880810. PubMed ID: 35795658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy.
    Abou Khouzam R; Goutham HV; Zaarour RF; Chamseddine AN; Francis A; Buart S; Terry S; Chouaib S
    Semin Cancer Biol; 2020 Oct; 65():140-154. PubMed ID: 31927131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment.
    Wei J; Hu M; Du H
    Front Immunol; 2022; 13():845923. PubMed ID: 35281061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite".
    Arina A; Gutiontov SI; Weichselbaum RR
    Clin Cancer Res; 2020 Jun; 26(12):2777-2782. PubMed ID: 32047000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.